Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202485 | PMC |
http://dx.doi.org/10.4103/idoj.IDOJ_417_20 | DOI Listing |
Trop Doct
October 2024
Department of Internal Medicine, NAUTH, Nnewi, Anambra State, Nigeria.
Histoid leprosy is an uncommon variant of lepromatous leprosy. It poses a diagnostic challenge because of its distinctive clinical and histopathological features. It presents as smooth papules and nodules that rarely ulcerate.
View Article and Find Full Text PDFBMJ Case Rep
July 2024
Dermatology, Venereology and Leprology, Dr D Y Patil Medical College Hospital and Research Centre, Dr D Y Patil Vidyapeeth, Pune, India.
JAAD Case Rep
March 2024
Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
Int J Dermatol
April 2024
Department of Dermatology, Venereology and Leprosy and Department of Pathology, Dr Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India.
The current goal of Zero Leprosy focuses on the interruption of the transmission of infection within endemic regions. While the role of the skin in the transmission dynamics of leprosy has not been clearly delineated, recent research on the environmental presence of lepra bacilli brings this aspect back into focus. We present a case of lepromatous leprosy with perforated-appearing histoid lesions on the palms and soles, demonstrating the presence of lepra bacilli throughout the epidermis.
View Article and Find Full Text PDFDiagnostics (Basel)
December 2023
Department of Dermatology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Currently, over 200,000 new cases of leprosy are reported annually worldwide. Although leprosy was thought to have been eradicated in Taiwan, a few new cases still occur annually. Protean clinical manifestations of leprosy and immunological reactions result in delayed diagnoses.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!